Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2025

 Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2025, the following resources were managed through the liquidity account: 327 750 shares€ 112,376 In the first half of 2025, it was negotiated a total of:Purchases249,004 shares€ 180,297769 market transactionsSales280,915 shares€ 212,020967 market transactions It is recalled that: as of December 31, 2024, the following resources were managed through the liquidity...

 

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2025, the following resources were managed through the liquidity account:

1. 327 750 shares
2. € 112,376

In the first half of 2025, it was negotiated a total of:

Purchases	249,004 shares	€ 180,297	769 market transactions
Sales	280,915 shares	€ 212,020	967 market transactions

It is recalled that:

1. as of December 31, 2024, the following resources were managed through the liquidity account:

• 359,661 shares
• € 80,653.30

2. at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:

• 164,183 shares
• € 246,158

3. when the liquidity program was initially established in 2016, the following resources were made available:

• € 500,000
  

 Contacts

Transgene: Lucie Larguier Chief Financial Officer +33 (0)3 88 27 91 00 [email protected]

Attachment

• 20250708_-_bilan_semestriel_H1_2025_EN